Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

BOSTiC : Training in Research Methods for Surgical Trainees - Wednesday, 27 April 2016 to Friday, 29 April 2016, 9am - 4pm

Research in surgery is challenging and requires multi-disciplinary collaboration with methodologists and clinicians to design and conduct high quality studies. The overall aim of all our training programmes is to inspire surgical trainees to learn and practise high quality research that will be relevant to surgical care of patients in the NHS.

The Oxford and Bristol Surgical Trials Units will be running a three day surgical research training event (BOSTiC) for surgical trainees in Spring 2016 (Wednesday 27th April to Friday 29th April inclusive) at the University of Bristol.

This course is designed for surgical trainees from all specialities wanting to learn about trials methodology, and to be involved in high quality research projects.

The programme consists of three back -to-back research training days and provides the opportunity for trainees to learn how to evaluate surgical interventions in well designed and conducted studies.

For further details and how to apply, please visit http://www.situ.ox.ac.uk/upcoming-events/bostic-2016

 

 

Similar stories

Celebrating Clinical Trials Day at NDORMS

To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain

A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.

Cemented hip replacement improves quality of life for patients over 60

The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.

FUTURE-GB looking ahead to 2022

FUTURE-GB has bounced into 2022 ahead of both predicted recruitment into Stage 2 (the Randomised Controlled Trial), and the sites open in Stage 2! Congratulations to all our sites for their hard work so far.